Generation Lab
Generation Lab sells the SystemAge biological age test, a $490 at-home diagnostic measuring 460+ biomarkers across 21 organ systems, sold direct-to-consumer and through 750+ clinics in 18 countries. The company targets health-conscious consumers, longevity clinics, and via Samsung Health integration, a global connected-care audience.
- Company typePrivate
- Founded2023
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Generation Lab does
Generation Lab is a longevity diagnostics company that sells the SystemAge biological age test, a one-time $490 cheek-swab/blood-based consumer and clinical diagnostic measuring 460+ biomarkers across 21 organ systems to quantify biological versus chronological aging. The product is delivered via a needle-free at-home blood collection device, paired with a personalized action plan and optional professional consultation and retesting, and is offered both direct-to-consumer through the company's website and through a network of 750+ affiliated clinics across 18 countries.
The underlying technology is an epigenetic and biomarker analysis platform informed by over 20 years of academic aging research from co-founder and Chief Science Officer Dr. Irina Conboy (UC Berkeley), including foundational work on aging reversal and DNA methylation biomarkers. The system is described as built on over 300 million human-aging data points and claims 99% accuracy across 1,605 test cases for the SystemAge 2.1 version released in June 2026. Generation Lab operates a hybrid business model: direct-to-consumer e-commerce via generationlab.com at $490 per test, plus a B2B2C distribution model where 750+ clinics purchase kits and resell testing to their patients. Distribution has expanded via strategic partnerships, most notably integration into the Samsung Health ecosystem (77 million monthly active users) announced at VivaTech 2026, and a Hall of Fame Health alliance for elite athletes and executives.
The company is venture-backed at $15 million in total disclosed funding, with an $11 million Accel-led seed round closed in October 2025 and an earlier undisclosed pre-seed from Transpose Platform and a Sequoia China founding partner in January 2024. The company was founded in 2023, launched out of stealth in 2024, employs 1-10 people, and is headquartered in Burlingame, California at a 12,300 sq ft life science campus. Co-founders Alina Su (CEO) and Michael Suswal (COO) lead the company alongside Dr. Conboy.
Generation Lab firmographics
Firmographics- Name
- Generation Lab
- Legal name
- Generation Lab
- Website
- https://generationlab.co
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Generation Lab sells the SystemAge biological age test, a $490 at-home diagnostic measuring 460+ biomarkers across 21 organ systems, sold direct-to-consumer and through 750+ clinics in 18 countries. The company targets health-conscious consumers, longevity clinics, and via Samsung Health integration, a global connected-care audience.
- Ownership category
- akta.pro rank
Generation Lab industry classification
Industry- Product category
- Longevity Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays (HLAAALAN)
- akta.pro secondary industries
- Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where Generation Lab is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Generation Lab business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- SystemAge Test Kits: One-time purchase of biological age test kits sold directly to consumers through the website and through clinic partners. The test measures biological aging across multiple organ systems and provides a comprehensive aging report with personalized action plan.
- Clinic/Provider Distribution: B2B2C model where the company provides test kits and platform access to clinics, which then offer tests to their patients. Clinics pay for platform access and pass the cost to consumers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | SystemAge Blood Test - $490 per test |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Generation Lab product offering
Product offeringCore offering
Generation Lab offers the SystemAge biological age diagnostic platform that measures over 460 biomarkers across 21 organ systems from a single needle-free blood draw. The platform is delivered as an at-home test kit (priced at $490) with a 15-minute self-administered collection process, followed by a personalized SystemAge Report and action plan. The platform is also distributed through 750+ affiliated clinics across 18 countries that offer the test to their patients.
Product overview
Generation Lab offers SystemAge, a unified biological age testing platform with multiple integrated components. The core product is SystemAge 2.1, a biological age test measuring 460+ biomarkers across 21 organ systems from a single needle-free blood draw. The platform includes three supporting modules: (1) an At-Home Needle-Free Blood Collection device for 15-minute sample collection, (2) a SystemAge Report with Personalized Action Plan providing full-body aging insights and early health risk identification, and (3) optional Professional Consultation and Retesting services. The platform is backed by over 20 years of aging research from co-founder Prof. Irina Conboy, and is currently deployed in over 750 clinics across 18 countries.
Differentiator
Problem solved
Functional benefit
Brands
- SystemAge: Biological age diagnostic platform that measures over 460 biomarkers across 21 organ systems from a single blood sample. Offers dedicated male and female versions with sex-specific aging analysis.
- SystemAge 2.1
Products and services
- SystemAge 2.1 Biological age testing platform that measures over 460 biomarkers across 21 organ systems from a single needle-free blood draw. Includes sex-specific male and female versions with sex-specific aging analysis, validated with 99% accuracy across 1,605 test cases. Available for direct consumer purchase at $490 per test and through 750+ affiliated clinics in 18 countries. Delivered with a SystemAge Report and personalized action plan, plus optional professional consultation and retesting.
Quantifiable outcome
- 99.9% diagnostic accuracy (original SystemAge platform)
- +5 more outcomes
Companies that use Generation Lab
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Generation Lab technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability3 records
Feature7 records
Generation Lab partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered major.
- SamsungmajorSamsung announced partnership with Generation Lab as part of its connected health vision at VivaTech 2026. Generation Lab's biological age tracking integrates with Samsung Health ecosystem (77M monthly active users) and SmartThings (460M devices) for preventive health platform. Samsung opened its Health SDK Suite to developers for integration.
- Hall of Fame HealthmajorStrategic collaboration announced during Super Bowl LX Week to develop a regenerative and longevity platform combining Generation Lab's diagnostics with advanced treatments. Targets athletes, executives, and industry leaders with personalized longevity protocols.
- Regen TherapymajorPartner in Hall of Fame Health's regenerative and longevity platform alongside Generation Lab and Beverly Hills Rejuvenation Center.
- Beverly Hills Rejuvenation CentermajorPartner in Hall of Fame Health's regenerative and longevity platform alongside Generation Lab and Regen Therapy.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
Generation Lab competitors and assessment
Company assessmentDirect peers
- Function Health: Function Health sells comprehensive annual blood-based diagnostics with personalized insights for health-conscious consumers. It is a direct competitor on consumer longevity diagnostics, breadth of biomarkers, and subscription-style testing cadence.
- TruDiagnostic: TruDiagnostic is a direct competitor offering epigenetic biological age testing (e.g., DunedinPACE, GrimAge) with a clinic and provider channel model, directly overlapping Generation Lab's SystemAge in product, customer, and delivery mechanism.
- myDNAge: myDNAge offers epigenetic biological age testing based on DNA methylation, directly comparable to Generation Lab's SystemAge in scientific methodology, biomarker focus, and consumer target market.
- InsideTracker: InsideTracker offers personalized blood-based biomarker testing and wellness insights via DTC and B2B channels. It competes with Generation Lab on consumer longevity diagnostics, biomarker panels, and personalized action plans.
- TallyHealth: TallyHealth sells at-home biological age tests focused on aging biomarkers with consumer-facing longevity positioning. It is a direct peer on product, target buyer (health-conscious consumers), and go-to-market motion.
- GlycanAge: GlycanAge offers a direct-to-consumer biological age test based on glycan biomarkers, competing with Generation Lab on biological age testing accuracy, consumer branding, and clinic partnerships.
- Elysium Index: Elysium Index is a direct competitor that sells a biological age test based on epigenetic biomarkers to consumers, competing with SystemAge on accuracy claims, breadth of biomarkers, and direct-to-consumer longevity positioning.
Emerging players
- Viome: Viome sells at-home health diagnostics (microbiome, transcriptomics) with personalized recommendations. It overlaps with Generation Lab in DTC health diagnostics, consumer personalization, and longevity-adjacent positioning, though biology differs.
Others
- Zymo Research: Zymo Research supplies epigenetics and nucleic acid research tools and services, including DNA methylation analysis. It is an enabling/adjacent player whose technology underpins biological age tests like Generation Lab's.
Broad incumbents
- Thorne: Thorne is an established health and wellness brand with at-home testing and supplements. It competes with Generation Lab as a broader incumbent offering diagnostics alongside supplements, capturing consumer longevity spend.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Generation Lab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Generation Lab leadership team
Management profileNumber of profiles
Profiles3 records
Generation Lab funding detail
Funding detailFunding overview
Funding rounds2 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Generation Lab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Generation Lab
What does Generation Lab do?
Generation Lab offers the SystemAge biological age diagnostic platform that measures over 460 biomarkers across 21 organ systems from a single needle-free blood draw. The platform is delivered as an at-home test kit (priced at $490) with a 15-minute self-administered collection process, followed by a personalized SystemAge Report and action plan. The platform is also distributed through 750+ affiliated clinics across 18 countries that offer the test to their patients.
Is Generation Lab a public or private company?
Generation Lab is a private company. It is classified as venture growth investor backed and is currently operating.
When was Generation Lab founded?
Generation Lab was founded in 2023. It employs 11 to 50 people.
Where is Generation Lab based?
Generation Lab is headquartered in San Francisco, United States, in the North America region.
How does Generation Lab make money?
Two revenue lines are on record. SystemAge Test Kits are the primary driver. The others are clinic/Provider Distribution.
Who are Generation Lab's main competitors?
Direct peers on record are Function Health, TruDiagnostic, myDNAge, InsideTracker, TallyHealth, GlycanAge and Elysium Index. Viome is listed as an emerging player. Zymo Research is listed as an others. Thorne is listed as a broad incumbent.
Does Generation Lab have an API?
No public API is recorded for Generation Lab.
What industry is Generation Lab in?
Generation Lab's product category is Longevity Diagnostics. Its primary akta.pro industry code is HLAAALAN, Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays, with a secondary code of HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 621511 and its SIC code is 8071.